Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jun
2
2014
Federal Court Vacates 340B Rule Regarding Orphan Drugs McDermott Will & Emery
Feb
7
2019
2018 Digital Health Year in Review: Focus on Care Coordination and Reimbursement McDermott Will & Emery
Feb
22
2019
Annual EU Competition Review 2018 McDermott Will & Emery
Feb
24
2022
Federal Circuit Divided on Whether Skinny Labeling Compliance Precludes Inducement or Supports Equitable Estoppel McDermott Will & Emery
Sep
26
2014
Merck Boosts Life Sciences Industry with Sigma-Aldrich Acquisition McDermott Will & Emery
Oct
28
2014
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates McDermott Will & Emery
Apr
29
2019
Health Care Enforcement Quarterly Roundup | Q1 2019 McDermott Will & Emery
May
27
2022
McDermottPlus Check-Up: May 27, 2022 McDermott Will & Emery
Feb
9
2015
Out-of-Market Divestiture Required to Resolve Competitive Concerns McDermott Will & Emery
Sep
6
2022
Healthcare Regulatory Check-Up August 2022: Other Notable Developments McDermott Will & Emery
Aug
21
2019
Third Circuit Upholds Decision Blocking Trump Administration’s Birth Control Rules McDermott Will & Emery
Aug
30
2019
FDA Regulatory Check-Up: CBD and Dietary Supplements McDermott Will & Emery
Sep
27
2019
Equivalent Disclosure Used To Satisfy Written Description Requirement McDermott Will & Emery
Oct
4
2019
McDermottPlus Check-up: October 4, 2019 McDermott Will & Emery
Jan
12
2016
Federal Trade Commission Policy Statement on Deceptively Formatted Advertisements McDermott Will & Emery
Dec
20
2019
EPA Approves Use of 10 Pesticide Products on Hemp McDermott Will & Emery
Mar
8
2023
This Week in 340B: February 28 – March 6, 2023 McDermott Will & Emery
Mar
31
2023
McDermott+Consulting Check-Up: March 31, 2023 McDermott Will & Emery
Apr
11
2023
This Week in 340B: April 4 – 10, 2023 McDermott Will & Emery
Mar
30
2016
Reformulated OxyContin Patents Invalid McDermott Will & Emery
Mar
17
2020
Clean Hands Can Stop More than COVID-19: Antitrust Risks in Times of Supply and Demand Shocks McDermott Will & Emery
Mar
18
2020
CMS Rolls Out Part D Insulin Payment Model: Aims to Lower Out-of-Pocket Expenses McDermott Will & Emery
Mar
23
2020
TTB and FDA Relax Restrictions on the Production of Hand Sanitizers by Alcohol Manufacturers McDermott Will & Emery
Jun
22
2023
Under High Pressure: New Mechanism of Action Can’t Save Drug Administration Claims McDermott Will & Emery
Jun
27
2023
Trending in Telehealth: June 13 – 21, 2023 McDermott Will & Emery
Jul
2
2016
Second Circuit Affirms Dismissal of Sham Citizen Petition Claim, Summary Judgment on False Advertising Claims McDermott Will & Emery
Sep
14
2023
Key Takeaways | Hospital and Health System Digital Health Spotlight: It’s all About the Patient! McDermott Will & Emery
Sep
19
2023
Top Takeaways | Specialty Spotlight: Gastroenterology McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins